verapamil has been researched along with nisoldipine in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (50.00) | 18.7374 |
| 1990's | 16 (25.81) | 18.2507 |
| 2000's | 8 (12.90) | 29.6817 |
| 2010's | 7 (11.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brouillette, WJ; Brown, GB; Zha, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dessy, C; Dion, R; Godfraind, T; Salomone, S; Schoevaerts, JC; Verhelst, B | 1 |
| Hawes, EM; Jenkins, SH; Watts, JA; Williams, TC | 1 |
| Belousov, Y; Kushnaryov, V | 1 |
| Abbate, R; Boddi, M; Coppo, M; Gensini, GF; Neri Serneri, GG; Prisco, D; Rostagno, C | 1 |
| Burkart, F; Kiowski, W; Pfisterer, M | 1 |
| Coghlan, JP; Denton, DA; Hardy, KJ; Johnson, EI; McDougall, JG; Scoggins, BA; Wright, RD | 1 |
| Kidwell, GA; Muir, WW; Schaal, SF | 1 |
| Lund-Johansen, P; Omvik, P | 1 |
| Bodewei, R; Hering, S; Schubert, B; Wollenberger, A | 1 |
| Coghlan, JP; Denton, DA; Johnson, EI; McDougall, JG; Scoggins, BA; Wright, RD | 2 |
| Bae, SJ; Herbette, LG; Kitamura, S; Sturtevant, JM | 1 |
| Dillon, JS; Nayler, WG; Sturrock, WJ | 1 |
| Elliott, HL; Pasanisi, F; Reid, JL; Sumner, DJ | 1 |
| Frais, MA; Jackson, N; Midtbo, KA; Reynolds, G; Sharma, S; Silke, B; Taylor, SH; Verma, SP | 1 |
| Elliott, HL; Jones, CR; Pasanisi, F; Reid, JL | 1 |
| Ilias, W; Steinbereithner, K | 1 |
| Fujita, I; Irita, K; Minakami, S; Takeshige, K; Yoshitake, J | 1 |
| Barbieri, L; Camerini, F; Mestroni, L | 1 |
| Karasawa, A; Kubo, K; Nakamizo, N; Oka, T | 1 |
| Harrison, GG; Morrell, DF; Wright, IG | 1 |
| Bowditch, J; Dow, JW; Nigdikar, SV | 1 |
| Barradas, MA; Dandona, P; Jeremy, JY; Mikhailidis, DP | 1 |
| Joubert, WS; Kociszewska, VJ; Meyer, AC; Meyer, BJ; Nieuwenhuis, JJ | 1 |
| Aizawa, T; Enyeart, JJ; Hinkle, PM | 1 |
| Bellemann, P | 1 |
| Kass, RS; Sanguinetti, MC | 1 |
| Schwartz, A; Tsai, LI; Wang, T | 1 |
| Lefer, AM; Okamatsu, S; Peck, RC | 1 |
| Bewtra, A; Cheng, JB; Townley, RG | 1 |
| Blasini, R; Brügmann, U; Rudolph, W | 1 |
| Hume, JR; Uehara, A | 1 |
| Altura, BM; Altura, BT | 1 |
| Francis, PD; Gaum, WE; Hannon, DW; Lathrop, DA; Millard, RW; Nakaya, H; Schwartz, A; Valle-Aguilera, JR | 1 |
| Brooks, HL; Gross, GJ; Meils, CM; Warltier, DC | 1 |
| Churchill, TA; Fuller, BJ; Green, CJ | 1 |
| Cingolani, H; Rinaldi, G | 1 |
| Aronson, R; Ming, Z; Nordin, C | 1 |
| Berke, G; Binah, O; Hoffman, BF; Rosen, D | 1 |
| Hyson, DA; Kappagoda, CT; Thomson, AB | 2 |
| Hair, WM; Hughes, AD; Martin, G; Sever, PS; Sunman, W | 1 |
| Agrotis, A; Bobik, A; Little, PJ; Saltis, J | 1 |
| Kikuchi, K; Sugawara, H; Tobise, K | 1 |
| Hyson, DH; Kappagoda, CT; Keelan, M; Thomson, AB | 1 |
| Hirano, Y; Hiraoka, M; Sawanobori, T; Zhang, S | 1 |
| Akimoto, Y; Fujii, A; Matsumoto, H; Noji, I | 1 |
| Doyle, KM; Kirby, BP; Murphy, D; Shaw, GG | 1 |
2 review(s) available for verapamil and nisoldipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Calcium antagonists in congestive heart failure].
Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Diltiazem; Felodipine; Heart Failure; Hemodynamics; Humans; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Verapamil | 1988 |
5 trial(s) available for verapamil and nisoldipine
| Article | Year |
|---|---|
The effects of nisoldipine, diltiazem, nifedipine, and verapamil on hemodynamic parameters and red blood cells-platelet interactions in patients with arterial hypertension.
Topics: Adult; Aged; Arteries; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Diltiazem; Erythrocytes; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nisoldipine; Verapamil | 1991 |
Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension.
Topics: Adult; Calcium Channel Blockers; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nisoldipine; Physical Exertion; Time Factors; Verapamil | 1987 |
The effect of calcium channel blockers on alpha 1- and alpha 2-adrenoceptor-mediated vascular responsiveness in man.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Hemodynamics; Humans; Male; Nisoldipine; Receptors, Adrenergic, alpha; Regional Blood Flow; Verapamil | 1985 |
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiazem; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Prospective Studies; Random Allocation; Verapamil | 1987 |
[Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Long-Term Care; Nifedipine; Nisoldipine; Nitroglycerin; Verapamil | 1984 |
55 other study(ies) available for verapamil and nisoldipine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
Topics: Calcium; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Nisoldipine; Vasoconstriction; Verapamil | 1992 |
Effects of nisoldipine on the no-reflow phenomenon in globally ischemic rat hearts.
Topics: Analysis of Variance; Animals; Coronary Circulation; Coronary Disease; Energy Metabolism; In Vitro Techniques; Myocardial Contraction; Myocardial Reperfusion; Nisoldipine; Rats; Rats, Inbred Strains; Verapamil | 1990 |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
Topics: Adult; Blood Platelets; Calcium; Calcium Channel Blockers; Diltiazem; Female; Humans; In Vitro Techniques; Male; Nifedipine; Nisoldipine; Nitrendipine; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Verapamil | 1991 |
Direct vascular and myocardial effects of nisoldipine.
Topics: Adult; Aged; Blood Pressure; Brachial Artery; Cardiac Output; Coronary Vessels; Female; Heart; Humans; Hypertension; Infusions, Intra-Arterial; Male; Middle Aged; Nisoldipine; Regional Blood Flow; Vascular Resistance; Verapamil | 1990 |
Ca antagonists do not alter aldosterone secretion during established Na depletion.
Topics: Adrenal Glands; Aldosterone; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Edetic Acid; Female; Gallopamil; Hydrocortisone; Indenes; Ion Channels; Lanthanum; Nifedipine; Nisoldipine; Ryanodine; Sheep; Sodium; Verapamil | 1985 |
Stereospecific effects of disopyramide enantiomers following pretreatment of canine cardiac Purkinje fibers with verapamil and nisoldipine.
Topics: Action Potentials; Animals; Disopyramide; Dogs; Heart Conduction System; In Vitro Techniques; Membrane Potentials; Nifedipine; Nisoldipine; Purkinje Fibers; Stereoisomerism; Verapamil | 1987 |
Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine.
Topics: Animals; Calcium; Calcium Channel Blockers; Diltiazem; Gallopamil; Glioma; Ion Channels; Neuroblastoma; Neurons; Nifedipine; Nisoldipine; Tumor Cells, Cultured; Verapamil | 1987 |
Role of Ca2+ in response of aldosterone to stimulation by angiotensin II in vivo.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Hydrocortisone; Lanthanum; Nifedipine; Nisoldipine; Sheep; Verapamil | 1988 |
The effects of calcium channel blocking drugs on the thermotropic behavior of dimyristoylphosphatidylcholine.
Topics: Calcium Channel Blockers; Calorimetry, Differential Scanning; Diltiazem; Dimyristoylphosphatidylcholine; Models, Biological; Nifedipine; Nimodipine; Nisoldipine; Thermodynamics; Verapamil | 1989 |
Calcium antagonists and hypertension.
Topics: Aging; Aniline Compounds; Animals; Blood Pressure; Calcium Channel Blockers; Catecholamines; Dihydroalprenolol; Heart; Hypertension; In Vitro Techniques; Male; Membranes; Nisoldipine; Norepinephrine; Rats; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Adrenergic, beta; Verapamil | 1988 |
Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Topics: Adult; Blood Platelets; Calcium Channel Blockers; Humans; In Vitro Techniques; Male; Nifedipine; Nisoldipine; Platelet Aggregation; Receptors, Adrenergic, alpha; Verapamil; Yohimbine | 1985 |
Potentiation of pancuronium induced neuromuscular blockade by calcium channel blockers in vitro.
Topics: Animals; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Drug Synergism; Gallopamil; Male; Neuromuscular Junction; Nifedipine; Nisoldipine; Pancuronium; Rats; Rats, Inbred Strains; Synaptic Transmission; Verapamil | 1985 |
Calcium channel antagonist induced inhibition of superoxide production in human neutrophils. Mechanisms independent of antagonizing calcium influx.
Topics: Calcium; Calcium Channel Blockers; Diltiazem; Egtazic Acid; Humans; Kinetics; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Nifedipine; Nisoldipine; Protein Kinase C; Superoxides; Tetradecanoylphorbol Acetate; Verapamil | 1986 |
Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Injections, Intravenous; Male; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Rats; Rats, Inbred SHR; Verapamil | 1988 |
The effects of calcium channel blocking drugs on halothane initiation of malignant hyperthermia in MHS swine and on the established syndrome.
Topics: Anesthesia, General; Animals; Calcium Channel Blockers; Diltiazem; Flunarizine; Halothane; Malignant Hyperthermia; Nifedipine; Nisoldipine; Swine; Verapamil | 1988 |
Calcium antagonists and adenine nucleotide metabolism in rat heart.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Bepridil; Calcium Channel Blockers; Heart; Myocardium; Nifedipine; Nisoldipine; Pyrrolidines; Rats; Verapamil | 1986 |
Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Topics: Calcium Channel Blockers; Humans; In Vitro Techniques; Nifedipine; Nisoldipine; Physical Exertion; Platelet Aggregation; Verapamil | 1986 |
Dihydropyridine calcium antagonists depress the amplitude of the plasma melatonin cycle in baboons.
Topics: Animals; Calcium Channel Blockers; Male; Melatonin; Nifedipine; Nisoldipine; Nitrendipine; Papio; Verapamil | 1986 |
Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
Topics: Animals; Calcium Channel Blockers; Cell Line; Growth Hormone; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Pituitary Gland; Pituitary Neoplasms; Potassium Chloride; Prolactin; Rats; Thyrotropin-Releasing Hormone; Verapamil | 1985 |
Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Calcium; Calcium Channel Blockers; Cells, Cultured; Kinetics; Myocardial Contraction; Myocardium; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Nitrendipine; Receptors, Drug; Verapamil | 1984 |
Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists.
Topics: Animals; Binding Sites; Cattle; Dihydropyridines; Electrophysiology; Heart Conduction System; Ion Channels; Membrane Potentials; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Purkinje Fibers; Pyridines; Verapamil | 1984 |
Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum.
Topics: Animals; Calcium Channel Blockers; Calcium-Transporting ATPases; Centrifugation, Density Gradient; Diltiazem; Dogs; Felodipine; In Vitro Techniques; Microsomes; Muscles; Myocardium; Nifedipine; Nisoldipine; Potassium Chloride; Rabbits; Sarcoplasmic Reticulum; Species Specificity; Verapamil | 1984 |
Effect of calcium channel blockers on arachidonate-induced sudden death in rabbits.
Topics: Animals; Arachidonic Acids; Calcium Channel Blockers; Death, Sudden; Ion Channels; Liver; Lysosomes; Nifedipine; Nisoldipine; Pancreas; Pyridines; Rabbits; Thromboxane B2; Verapamil | 1981 |
Identification of calcium antagonist receptor binding sites using (3H)nitrendipine in bovine tracheal smooth muscle membranes.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Cattle; Cromolyn Sodium; Kinetics; Muscle, Smooth; Nifedipine; Nisoldipine; Nitrendipine; Receptors, Nicotinic; Trachea; Verapamil | 1984 |
Voltage clamp comparison of the organic calcium channel blockers D-600 and nisoldipine.
Topics: Animals; Anura; Atrial Function; Calcium Channel Blockers; Electrophysiology; Gallopamil; Heart Atria; In Vitro Techniques; Kinetics; Nifedipine; Nisoldipine; Verapamil | 1984 |
Calcium antagonists and stimulus-secretion coupling of aldosterone.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Nifedipine; Nisoldipine; Potassium; Sheep; Sodium; Transplantation, Autologous; Verapamil | 1984 |
Pharmacologic inhibition of cerebral vasospasm in ischemia, hallucinogen ingestion, and hypomagnesemia: barbiturates, calcium antagonists, and magnesium.
Topics: Animals; Barbiturates; Brain Ischemia; Calcium Channel Blockers; Cerebral Arteries; Magnesium; Metabolic Diseases; Microcirculation; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Phencyclidine; Rats; Verapamil; Water Supply | 1983 |
Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.
Topics: Animals; Benzazepines; Bundle of His; Calcium Channel Blockers; Culture Techniques; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Atria; Heart Conduction System; Hemodynamics; Humans; Membrane Potentials; Nifedipine; Nisoldipine; Purkinje Fibers; Pyridines; Verapamil | 1982 |
Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.
Topics: Animals; Benzazepines; Calcium; Coronary Circulation; Coronary Disease; Diltiazem; Dogs; Female; Hemodynamics; Male; Nifedipine; Nisoldipine; Pyridines; Verapamil | 1981 |
The importance of calcium-related effects on energetics at hypothermia: effects of membrane-channel antagonists on energy metabolism of rat liver.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Chlorpromazine; Cryopreservation; Energy Metabolism; In Vitro Techniques; Ion Channels; Ion Transport; Liver; Male; Nifedipine; Nisoldipine; Organ Preservation; Prenylamine; Rats; Rats, Sprague-Dawley; Verapamil | 1995 |
Relationship between baseline blood pressure and blood pressure decrease after calcium channel blockers in conscious rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Consciousness; Hypertension; Male; Nisoldipine; Nitrendipine; Nitroprusside; Rats; Rats, Wistar; Verapamil | 1994 |
Mechanism of current-induced early afterdepolarizations in guinea pig ventricular myocytes.
Topics: Action Potentials; Adenosine Diphosphate; Animals; Calcium; Cells, Cultured; Electric Stimulation; Guinea Pigs; Heart; Heart Ventricles; Kinetics; Nisoldipine; Potassium; Quinidine; Ryanodine; Sarcoplasmic Reticulum; Time Factors; Verapamil | 1994 |
Calcium channel blockers modify electrophysiological effects induced by lytic granules from cytotoxic T lymphocytes in guinea pig ventricular myocytes.
Topics: Action Potentials; Animals; Cadmium; Cadmium Chloride; Calcium Channel Blockers; Chlorides; Cobalt; Cytoplasmic Granules; Cytotoxicity, Immunologic; Guinea Pigs; Heart; Heart Ventricles; Hemolysis; In Vitro Techniques; Nisoldipine; T-Lymphocytes, Cytotoxic; Verapamil | 1994 |
Differential and interactive effects of calcium channel blockers and cholesterol content of the diet on jejunal uptake of lipids in rabbits.
Topics: Animals; Calcium Channel Blockers; Cholesterol; Cholesterol, Dietary; Fatty Acids; Jejunum; Linoleic Acid; Linoleic Acids; Lipid Metabolism; Male; Nisoldipine; Organ Size; Palmitic Acid; Palmitic Acids; Rabbits; Stearic Acids; Triglycerides; Verapamil | 1994 |
Effect of calcium antagonists on endothelin-induced contraction of isolated human resistance arteries: differences related to site of origin.
Topics: Adipose Tissue; Adult; Aged; Arteries; Calcium Channel Blockers; Calcium Channels; Diltiazem; Endothelins; Flunarizine; Humans; Membrane Potentials; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Myography; Nimodipine; Nisoldipine; Omentum; Vasoconstriction; Verapamil | 1993 |
Dihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells.
Topics: Calcium Channel Blockers; Cell Division; Cells, Cultured; Dihydropyridines; Diltiazem; DNA; Epidermal Growth Factor; Felodipine; Gene Expression Regulation; Genes, fos; Humans; Immunoblotting; Mammary Arteries; Muscle, Smooth, Vascular; Nisoldipine; Thymidine; Verapamil | 1993 |
Calcium channel blockers modify jejunal uptake of D-galactose in rabbits.
Topics: Animals; Calcium Channel Blockers; Galactose; Glucose; In Vitro Techniques; Jejunum; Male; Microvilli; Monosaccharide Transport Proteins; Nisoldipine; Permeability; Rabbits; Verapamil | 1996 |
Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
Topics: Adenosine Diphosphate; Animals; Antioxidants; Calcium Channel Blockers; Cell Membrane; Dihydropyridines; Diltiazem; Felodipine; Fumarates; Heart; Iron; Lipid Peroxidation; Male; Myocardium; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Verapamil | 1996 |
A high cholesterol diet blocks the effect of calcium channel blockers on the uptake of sugars in rabbit intestine.
Topics: Animals; Biological Transport; Body Weight; Calcium Channel Blockers; Carbohydrates; Cholesterol, Dietary; Dose-Response Relationship, Drug; Drug Interactions; Glucose; Intestinal Absorption; Jejunum; Male; Nisoldipine; Phosphodiesterase Inhibitors; Rabbits; Theophylline; Verapamil | 1997 |
Multiple modulations of action potential duration by different calcium channel blocking agents in guinea pig ventricular myocytes.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Guinea Pigs; Heart Ventricles; Manganese; Nisoldipine; Ventricular Function; Verapamil | 1997 |
Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Calcium Channel Blockers; Cell Culture Techniques; Cell Division; Collagen; Diltiazem; DNA; ErbB Receptors; Female; Fibroblasts; Flow Cytometry; Gingiva; Gingival Overgrowth; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Phenytoin; Radiopharmaceuticals; Statistics as Topic; Tritium; Verapamil | 2001 |
Effect of L-type calcium channel antagonists on spermine-induced CNS excitation in vivo.
Topics: Amines; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Central Nervous System; Convulsants; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Female; Gabapentin; gamma-Aminobutyric Acid; Mice; Neurodegenerative Diseases; Neurons; Nisoldipine; Nitrendipine; Spermine; Synapses; Synaptic Transmission; Verapamil | 2005 |